These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND uPA AND Prognosis
27 results:

  • 1. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
    Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
    Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Stromal coexpression of upa/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
    Singer CF; Filipits M; Jahn SW; Abete L; Jakesz R; Greil R; Bauernhofer T; Kwasny W; Seifert M; Fitzal F; Kastner M; Schmitt M; Moinfar F; Gnant M
    Breast; 2019 Aug; 46():101-107. PubMed ID: 31132475
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator receptor (upaR) expression enhances invasion and metastasis in RAS mutated tumors.
    Mauro CD; Pesapane A; Formisano L; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Monteleone F; Zambrano N; Fontanini G; Servadio A; Pignataro G; Grumetto L; Lavecchia A; Bruzzese D; Iaccarino A; Troncone G; Veneziani BM; Montuori N; Placido S; Bianco R
    Sci Rep; 2017 Aug; 7(1):9388. PubMed ID: 28839232
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical prospects of tumor-associated proteases and their tissue inhibitors investigation in oncologic patient].
    Gershteĭn ES; Kushlinskiĭ NE
    Vestn Ross Akad Med Nauk; 2013; (5):16-27. PubMed ID: 24000664
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
    Lin Y; Peng N; Li J; Zhuang H; Hua ZC
    Mol Cancer; 2013 Jun; 12():54. PubMed ID: 23758884
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Gelsolin induces colorectal tumor cell invasion via modulation of the urokinase-type plasminogen activator cascade.
    Zhuo J; Tan EH; Yan B; Tochhawng L; Jayapal M; Koh S; Tay HK; Maciver SK; Hooi SC; Salto-Tellez M; Kumar AP; Goh YC; Lim YC; Yap CT
    PLoS One; 2012; 7(8):e43594. PubMed ID: 22927998
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition.
    Jacobsen B; Ploug M
    Curr Med Chem; 2008; 15(25):2559-73. PubMed ID: 18855679
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Differential proteome expression associated with urokinase plasminogen activator receptor (upaR) suppression in malignant epithelial cancer.
    Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
    J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Polymorphisms in the genes of the urokinase plasminogen activation system in relation to colorectal cancer.
    Försti A; Lei H; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
    Ann Oncol; 2007 Dec; 18(12):1990-4. PubMed ID: 17804466
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer.
    Seetoo DQ; Crowe PJ; Russell PJ; Yang JL
    J Surg Oncol; 2003 Mar; 82(3):184-93. PubMed ID: 12619063
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression correlates with upaR levels and is responsible for poor prognosis of colorectal cancer.
    Konno H; Baba M; Shoji T; Ohta M; Suzuki S; Nakamura S
    Clin Exp Metastasis; 2002; 19(6):527-34. PubMed ID: 12405290
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) expression in human colorectal carcinomas.
    Papadopoulou S; Scorilas A; Yotis J; Arnogianaki N; Plataniotis G; Agnanti N; Talieri M
    Tumour Biol; 2002; 23(3):170-8. PubMed ID: 12218297
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Plasmin/plasminogen system in colorectal cancer.
    Berger DH
    World J Surg; 2002 Jul; 26(7):767-71. PubMed ID: 11965442
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
    Nordengren J; Fredstorp Lidebring M; Bendahl PO; Brünner N; Fernö M; Högberg T; Stephens RW; Willén R; Casslén B
    Int J Cancer; 2002 Jan; 97(3):379-85. PubMed ID: 11774293
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer.
    Konno H; Abe J; Kaneko T; Baba M; Shoji A; Sunayama K; Kamiya K; Tanaka T; Suzuki S; Nakamura S; Urano T
    Jpn J Cancer Res; 2001 May; 92(5):516-23. PubMed ID: 11376560
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic importance of the soluble plasminogen activator receptor, supaR, in plasma from rectal cancer patients.
    Fernebro E; Madsen RR; Fernö M; Brünner N; Bendahl P; Christensen IJ; Johnson A; Nilbert M
    Eur J Cancer; 2001 Mar; 37(4):486-91. PubMed ID: 11267858
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.
    Abe J; Urano T; Konno H; Erhan Y; Tanaka T; Nishino N; Takada A; Nakamura S
    Cancer; 1999 Dec; 86(12):2602-11. PubMed ID: 10594855
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 2.